House lawmakers support US trade panel's probe into China's biotech sector and pricing practices

At least ten members of the U.S. House of Representatives have voiced support for a trade investigation targeting China’s biotechnology industry.

The investigation, led by a U.S. trade panel, will examine the sector’s market practices and pricing, with lawmakers urging the administration to take further action.

The move reflects growing concern in Washington about competitive fairness and could lead to policy measures affecting Chinese biotech firms.